2021 | Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan | SZU-MIN HSIEH ; Liu, Ming-Che; Chen, Yen-Hsu; Lee, Wen-Sen; Hwang, Shinn-Jang; Cheng, Shu-Hsing; Ko, Wen-Chien; Hwang, Kao-Pin; Wang, Ning-Chi; Lee, Yu-Lin; Lin, Yi-Ling; Shih, Shin-Ru; Huang, Chung-Guei; Liao, Chun-Che; Liang, Jian-Jong; Chang, Chih-Shin; Chen, Charles; Lien, Chia En; Tai, I-Chen; Lin, Tzou-Yien | The Lancet. Respiratory medicine | 87 | 81 | |
2023 | Week 96 Results of Switching from Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide among HIV/Hepatitis B Virus-Coinfected Patients | YU-SHAN HUANG ; Cheng, Chien-Yu; HSIN-YUN SUN ; Cheng, Shu-Hsing; Lu, Po-Liang; Lee, Chen-Hsiang; Lee, Yuan-Ti; Tsai, Hung-Chin; Yang, Chia-Jui; Liu, Chun-Eng; Liou, Bo-Huang; Lin, Shih-Ping; Huang, Sung-Hsi; Ho, Mao-Wang; Tang, Hung-Jen; CHIEN-CHING HUNG | Microbiology spectrum | 0 | 0 | |